| http://www.w3.org/ns/prov#value | - In attempts to overcome these obstacles, several strategies have been explored including the use of a low pathogenic avian influenza virus [22], baculovirus- expressed H5 HA [23], recombinant adenoviruses [24], [25] and the production of attenuated live seed virus with modified H5 HA [17], [26], [27].As an alternative to conventional egg-based influenza vaccine manufacturing, our laboratory and ot
|
